FDA & Alzheimer’s Research: The FDA accepted for review DYNE-251 (z-rostudirsen) for Duchenne muscular dystrophy exon 51 skipping, with priority review and a Jan. 21, 2027 action date; the Alzheimer’s Association also launched the PROTECT-Cog prevention study in London. Dementia Care: The LiBBY trial reported that a THC/CBD oral formulation reduced agitation in hospice-eligible late-stage dementia patients, a group often excluded from trials. Cancer & Supply Chains: Clinicians are adapting after a breast biopsy needle recall, while prostate cancer experts discuss how AI is starting to shape risk and treatment decisions. Mental Health Capacity: South Africa’s Western Cape opened a new 30-bed acute psychiatric unit at Eerste River Hospital to meet rising demand. Primary Care & Access: Kenya will cover Social Health Authority premiums for community health promoters and provide smartphones and kits; the Philippines’ Eastern Samar urged tighter coordination to overcome island and remote-area barriers. Policy & Costs: The U.S. flagged Tennessee-area hospitals for price-transparency issues; Pennsylvania approved $42M for rural health transformation projects. Nutrition & Public Health: Studies highlight benefits of breakfast for teen nutrient intake, caution that many “prebiotic” sodas may be sugar-heavy, and link a plant-forward “planetary health diet” with lower cardiovascular risk.